• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018 Product Image

Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

  • Published: January 2014
  • Region: Global
  • 77 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere
  • Bio-Rad Laboratories
  • Psychemedics Corporation
  • Quest Diagnostic
  • Randox Laboratories
  • MORE

'Drugs of Abuse Testing Market (Sample Based Testing - Urine, Saliva and Hair Onsite and laboratory Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018'

The global drugs of abuse testing market is rapidly growing due to the rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. Globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse.is also supporting the growth of the drugs of abuse testing market.

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. This report forecasts future potential of all these drugs of abuse testing markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key READ MORE >

Chapter 1 Preface
1.1 Report Description
1.2 Markets covered
1.3 Research methodology

Chapter 2 Executive Summary

Chapter 3 Drugs of Abuse Testing Market – Industry Analysis
3.1 Introduction
3.1.1 International drug trafficking
3.1.2 Drug trafficking and illicit drug use in North America
3.1.3 Drug trafficking and illicit drug use in Europe
3.1.4 Drug trafficking and illicit drug use in Asia-Pacific
3.2 Market Drivers
3.2.1 Globally rising consumption of illicit drugs
3.2.2 Adoption of drugs of abuse (DOA) testing at organizational level
3.2.3 Increased production of illicit drugs and their trade
3.2.4 Increasing death rates/road accidents due to drug abuse
3.3 Restraints
3.3.1 Social concerns associated with illicit drugs testing
3.3.2 Legalization of various drugs
3.3.3 Economic volatility and cost concerns

Chapter 4 Porter’s five force analysis
4.1 Bargaining power of buyers
4.2 Bargaining power of suppliers
4.3 Threat from new entrants
4.4 Intensity of rivalry
4.5 Threat from substitutes

Chapter 5 Global Drugs of Abuse Testing Market

Chapter 6 Drugs of Abuse Testing Market – Testing Technology Analysis
6.1 Immunoassay Technology
6.2 Chromatography Technology

Chapter 7 Drugs of Abuse Testing Market – Sample Analysis
7.1 Laboratory drug test
7.2 On-site screening test

Chapter 8 Single vs. Multiple Parameter Test

Chapter 9 Drugs of Abuse Market – Regional Segment Analysis
9.1 Scenario of drug testing in North America
9.1.1 Scenario of drug testing in the US
9.2 Scenario of drug testing in Europe
9.2.1 Scenario of drug testing in the UK
9.2.2 Scenario of drug testing in France
9.2.3 Scenario of drug testing in Germany
9.3 Scenario of drug testing in Asia-Pacific
9.3.1 Scenario of drug testing in India
9.3.2 Scenario of drug testing in China
9.3.3 Scenario of drug testing in Japan

Chapter 10 Recent Developments

Chapter 11 Company profiles
11.1 Roche Diagnostics
11.1.1 Overview
11.1.2 Products & Segments
11.1.3 Financial Performance
11.2 Quest Diagnostic
11.2.1 Overview
11.2.2 Products & Segments
11.2.3 Financial Performance
11.3 LabCorp (Laboratory Corporation of America)
11.3.1 Overview
11.3.2 Products & Segments
11.3.3 Financial Performance
11.4 Alere
11.4.1 Overview
11.4.2 Products and Segments
11.4.3 Financial Performance
11.5 Abbott Laboratories
11.5.1 Overview
11.5.2 Products & Segments
11.5.3 Financial Performance
11.6 Randox Laboratories
11.6.1 Overview
11.6.2 Products & Segments
11.6.3 Financial Performance
11.7 Psychemedics Corporation
11.7.1 Overview
11.7.2 Products & Services
11.7.3 Financial Performance
11.8 Bio-Rad Laboratories
11.8.1 Overview
11.8.2 Products & Segmentation
11.8.3 Financial Performance
11.9 Sonic Healthcare
11.9.1 Overview
11.9.2 Products & Services
11.9.3 Financial Performance
11.10 Thermo Fisher Scientific
11.10.1 Overview
11.10.2 Products & Segments
11.10.3 Financial performance

List of Figures

FIG. 1 Global illicit drug users (in millions) 2009-2011
FIG. 2 Porter’s five forces analysis for drugs of abuse testing market
FIG. 3 Drug abuse testing market strategic developments (2011-2013)
FIG. 4 Company revenues (USD million, 2011-2012)
FIG. 5 Company revenues (USD million, 2011 – 2012)
FIG. 6 Company revenues (USD million, 2011 – 2012)
FIG. 7 Company revenues (USD million, 2011 – 2012)
FIG. 8 Company revenues (USD million, 2011 – 2012)
FIG. 9 Company revenues (USD million, 2011 – 2012)
FIG. 10 Company revenues (USD million, 2011-2012)
FIG. 11 Company revenues (USD million, 2011-2012)
FIG. 12 Company revenues (USD million, 2011-2012)

List of Tables

TABLE 1 Illicit drug users in various parts of the world, by major drugs (% share, 2011)
TABLE 2 Drivers for drugs of abuse testing market: Impact analysis
TABLE 3 Restraints for drugs of abuse testing market: Impact analysis
TABLE 4 Global drugs of abuse testing market size, by geography 2008-2012 (USD million)
TABLE 5 Global drugs of abuse testing market size, by geography 2013-2018 (USD million)
TABLE 6 Some of the key market players offering drugs testing equipment and products
TABLE 7 Characteristics of different specimens for drug testing
TABLE 8 Global drugs of abuse testing market, by sample 2008-2012 (USD million)
TABLE 9 Global drugs of abuse testing market, by sample 2013-2018 (USD million)
TABLE 10 Advantage and disadvantage of laboratory drug screening test
TABLE 11 Advantage and disadvantage of on-site drug screening test
TABLE 12 Global drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 13 Global drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 14 Advantages of multi panel drug test over single paned drug test
TABLE 15 North American drugs of abuse testing market, by geography 2008-2012 (USD million)
TABLE 16 North American drugs of abuse testing market, by geography 2013-2018 (USD million)
TABLE 17 North American drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 18 North American drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 19 US drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 20 US drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 21 European drugs of abuse testing market, by geography 2008-2012 (USD million)
TABLE 22 European drugs of abuse testing market, by geography 2013-2018 (USD million)
TABLE 23 European drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 24 European drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 25 UK drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 26 UK drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 27 France drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 28 France drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 29 Germany drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 30 Germany drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 31 Asian drugs of abuse testing market, by geography 2008-2012 (USD million)
TABLE 32 Asian drugs of abuse testing market, by geography 2013-2018 (USD million)
TABLE 33 Asian drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 34 Asian drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 35 Indian drugs of abuse testing market, by test location 2008-2012 (USD thousand)
TABLE 36 Indian drugs of abuse testing market, by test location 2013-2018 (USD thousand)
TABLE 37 China drugs of abuse testing market, by test location 2008-2012 (USD thousand)
TABLE 38 China drugs of abuse testing market, by test location 2013-2018 (USD thousand)
TABLE 39 Japan drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 40 Japan drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 41 Major product launches in drugs of abuse testing market (2011-2013)
TABLE 42 Mergers and acquisitions in drugs of abuse testing market (2011-2013)
TABLE 43 Partnerships in drugs of abuse testing market (2011-2013)

Globally, the drugs of abuse testing market is witnessing significant growth due to rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. As a result, this market is expected to grow at a CAGR of about XX% during 2013 – 2018.

Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns.

North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and European countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market.

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only.

Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.

- Abbott Laboratories
- Alere
- Bio-Rad Laboratories
- LabCorp (Laboratory Corporation of America)
- Psychemedics Corporation
- Quest Diagnostic
- Randox Laboratories
- Roche Diagnostics
- Sonic Healthcare
- Thermo Fisher Scientific

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos